CenterBook Partners’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.91M Sell
170,229
-707,348
-81% -$15.8M 0.24% 111
2026
Q1
$14.9M Buy
877,577
+299,406
+52% +$6.42M 0.8% 20
2025
Q4
$14.8M Buy
578,171
+153,778
+36% +$3.54M 0.73% 26
2025
Q3
$9.13M Buy
424,393
+310,516
+273% +$7.06M 0.45% 47
2025
Q2
$2.51M Sell
113,877
-401,749
-78% -$8.81M 0.14% 186
2025
Q1
$11.5M Buy
515,626
+423,257
+458% +$9.12M 0.73% 28
2024
Q4
$1.59M Buy
+92,369
New +$1.43M 0.1% 246
2023
Q1
Sell
-75,565
Closed -$2.35M 444
2022
Q4
$2.35M Buy
75,565
+24,949
+49% +$902K 0.39% 74
2022
Q3
$1.88M Buy
50,616
+16,289
+47% +$610K 0.36% 79
2022
Q2
$997K Buy
34,327
+25,945
+310% +$929K 0.21% 172
2022
Q1
$431K Sell
8,382
-8,842
-51% -$379K 0.15% 233
2021
Q4
$867K Buy
+17,224
New +$964K 0.51% 56

Other funds holding PGNY

CenterBook Partners's PGNY Position: Q2 2026 in Review

CenterBook Partners reduced its Progyny (PGNY) stake by 81% in Q2 2026, selling an estimated $15.8M and leaving 170,229 shares worth $4.91M. The position accounts for 0.24% of the portfolio, ranked #111.

CenterBook Partners first reported a position in PGNY in Q4 2021 and has held it in 12 quarters since. The position peaked at $14.9M in Q1 2026. 312 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • CenterBook Partners held 170,229 shares of Progyny worth $4.91M as of Q2 2026.
  • CenterBook Partners sold 707,348 Progyny shares in Q2 2026, an estimated $15.8M.
  • Progyny made up 0.24% of CenterBook Partners's portfolio in Q2 2026, its #111 holding.
  • CenterBook Partners first reported a position in Progyny in Q4 2021 and has held it in 12 quarters since.
  • CenterBook Partners's Progyny position peaked at $14.9M in Q1 2026.
  • 312 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.